Histone H2AX Is a Mediator of Gastrointestinal Stromal Tumor Cell Apoptosis Following Treatment With Imatinib Mesylate

Cancer Research - United States
doi 10.1158/0008-5472.can-06-3497
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Severe Esophagitis in a Patient With Gastrointestinal Stromal Tumor Treated With Imatinib

Endoscopy
Gastroenterology
2009English

Primary Prostatic Extra-Gastrointestinal Stromal Tumor Treated With Imatinib Mesylate as Neoadjuvant and Adjuvant Therapy: A Case Report and Literature Review

OncoTargets and Therapy
OncologyPharmacology
2019English

RACK1 Overexpression Is Linked to Acquired Imatinib Resistance in Gastrointestinal Stromal Tumor

Oncotarget
Oncology
2016English

A Case of Postoperative Recurrence of Peritoneal Dissemination Due to Gastrointestinal Stromal Tumor of the Ileum Responding to Imatinib Mesylate

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2005English

Recurrent Gastrointestinal Stromal Tumor (GIST) of the Stomach Associated With a Novel C-Kit Mutation After Imatinib Treatment

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2006English

Sunitinib Malate for Gastrointestinal Stromal Tumour in Imatinib Mesylate–resistant Patients: Recommendations and Evidence

Current Oncology
Oncology
2010English

Imatinib Induced Severe Skin Reactions and Neutropenia in a Patient With Gastrointestinal Stromal Tumor

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Imatinib-Induced Hepatitis Treated by Corticosteroids in a Patient With Metastatic Gastrointestinal Stromal Tumor

Yeungnam University Journal of Medicine
2019English

Remarkable Response in a Case of Recurrent Gastrointestinal Stromal Tumor Treated With Low Dose Imatinib

Journal of Nihon University Medical Association
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy